Suwon-si, South Korea

Yun-Seok Cho


 

Average Co-Inventor Count = 8.6

ph-index = 1


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Yun-Seok Cho: Innovations in Eye Care

Introduction

Yun-Seok Cho, an accomplished inventor based in Suwon-si, South Korea, has made significant contributions to the field of eye care through his innovative breakthroughs. With a total of two patents to his name, he specializes in formulations aimed at preventing and treating macular degeneration.

Latest Patents

Among his latest innovations, Cho has developed an eye drop formulation that comprises a benzopyran derivative or a pharmaceutically acceptable salt. This eye drop formulation features a stabilizing agent, propylene glycol, and a pH controlling agent in an aqueous medium, with a pH ranging from 4.0 to 5.0. The invention emphasizes the high concentration of the active ingredient, ensuring excellent stability and long shelf life for the product, which can be instrumental in treating macular degeneration.

Additionally, Cho's pharmaceutical composition for preventing or treating macular degeneration comprises benzopyran derivatives substituted with secondary amines, including imidazole or their pharmaceutically acceptable salts, presented in the form of eye drops.

Career Highlights

Throughout his career, Yun-Seok Cho has been associated with prominent institutions such as Hanlim Pharmaceutical Co., Ltd. and the Korea Research Institute of Chemical Technology. His expertise in pharmaceutical compositions has cemented his reputation as a leader in the field.

Collaborations

Cho has collaborated with notable colleagues, including Geun-Hyeog Lee and Dong-Yeop Shin, to enhance his research and development efforts, ultimately leading to innovative breakthroughs in eye care products.

Conclusion

Yun-Seok Cho's contributions to the pharmaceutical sector, particularly in eye care, demonstrate his dedication to advancing medical treatments for macular degeneration. His patents reflect a commitment to innovation and effectiveness, promising better outcomes for patients suffering from vision-related ailments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…